Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis
Bisma Khwaja1, Finosh G Thankam1, Devendra K Agrawal2
1Department of Translational Research, Western University of Health Sciences, Pomona, CA, 91766, USA.
Insights
Mitochondrial damage-associated molecular patterns (mtDAMPs) and oxidized LDL (oxLDL) trigger sterile inflammation in atherosclerosis by activating the NLRP3 inflammasome. This pathway promotes inflammatory cytokines, driving plaque formation and cardiovascular disease.
Area of Science:
- Cardiovascular Pathology
- Immunology
- Molecular Biology
Background:
- Atherosclerosis leads to severe cardiovascular diseases, with oxidized low-density lipoprotein (oxLDL) accumulation being a key factor.
- Emerging research highlights mitochondrial damage-associated molecular patterns (mtDAMPs) as critical initiators of sterile inflammation in atherosclerosis, acting alongside oxLDL.
Purpose of the Study:
- To critically review and discuss the central role of the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome in mtDAMP-induced sterile inflammation in atherosclerosis.
- To explore the involvement of specific components like caspase-1, pregnane X receptor (PXR), adenosine monophosphate activated protein kinase (AMPK), protein phosphatase 2A (PP2A), and thioredoxin-interacting protein (TXNIP).
- To examine the role of downstream cytokines, including interleukin-1β (IL-1β) and IL-18, as potential mediators of atherosclerosis.
Main Methods:
- Literature review and critical discussion of existing research on mtDAMPs, oxLDL, and the NLRP3 inflammasome in atherosclerosis.
- Analysis of signaling pathways involved in mtDAMP-mediated inflammation.
- Identification of key molecular components and downstream cytokines implicated in the atherosclerotic process.
Main Results:
- mtDAMPs, including mitochondrial DNA (mtDNA) and other components, are implicated in proatherogenic roles.
- mtDAMPs activate the NLRP3 inflammasome, leading to the secretion of pro-inflammatory cytokines like IL-1β.
- This inflammatory cascade contributes to vascular smooth muscle and fibroblast proliferation, arterial wall thickening, and plaque formation.
Conclusions:
- The NLRP3 inflammasome plays a central role in mtDAMP-induced sterile inflammation in atherosclerosis.
- Understanding the interplay between mtDAMPs and oxLDL offers significant potential for developing novel therapeutic strategies against atherosclerosis.
- Targeting the NLRP3 inflammasome pathway presents a promising avenue for novel therapeutic interventions in atherosclerosis.
Abstract:
Atherosclerosis results in life-threatening cardiovascular pathologies, including ischemic heart disease, stroke, myocardial infarction, and peripheral arterial disease. The role of increased serum low-density lipoprotein (LDL) and resultant accumulation of oxidized-LDL (oxLDL) in atheroma formation is well established. Recent findings elucidate the significance of mitochondrial damage-associated molecular patterns (mtDAMPs) in triggering sterile inflammation in concert with oxLDL. The mtDAMPs including mitochondrial DNA (mtDNA), cytochrome C, cardiolipin, heat shock protein 60 (HSP60), mitochondrial transcription factor A (TFAM), and N-formyl peptides, are expected to possess proatherogenic roles. However, limited data are available in the literature. The mtDAMPs initiate sterile inflammation in atherosclerotic lesions via numerous signaling pathways, most of which converge to the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome. Priming the activation of the NLRP3 inflammasome, mtDAMPs promote secretion of proinflammatory cytokines, including interleukin-1β (IL-1β), implicated in atherosclerotic lesions through vascular smooth muscle and fibroblast proliferation, arterial wall thickening, and plaque formation. In this article we critically reviewed and discussed the central role of the NLRP3 inflammasome in mtDAMP-induced sterile inflammation in atherosclerosis with specific components including caspase-1, pregnane X receptor (PXR), adenosine monophosphate activated protein kinase (AMPK), protein phosphatase 2A (PP2A), thioredoxin-interacting protein (TXNIP), and downstream cytokines including IL-1β and IL-18 as potential mediators of atherosclerosis. Better understanding of the proinflammatory effects of mtDAMPs and its pathological association with oxLDL possess immense translational significance for novel therapeutic intervention.
Related Concept Videos
Mitochondrial Membranes
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management
Mitochondria
Coronary Artery Disease I: Introduction


